As a founding member of FACT, Dr. Vaughn helped to establish the initial standards for the field of cell therapy and the core voluntary accreditation process. He served on the Board of directors for 6 years.In Memoriam - William Perry Vaughn, MD | FACT
FACT has partnered with ISCT, as the global steward fostering the translation of cell and gene therapies to the clinic, providing educational resources and networking, on this special offer that includes 3 complimentary technologist memberships with FACT referral code [FACTLAB]*.Read About the Features of an ISCT Lab Membership
Tumor-infiltrating lymphocytes (TILs) can recognize and kill cancer cells. This webinar will provide a broad introduction to TILs and a review of current clinical experience and unique considerations in TIL manufacturing. Presenters will also discuss the need for establishing safety and efficacy quality benchmarks for TILs.
• Parameswaran Hari, MD, MRCP, DRCPath, MS, from Iovance Biotherapeutics
• John Mullinax, MD, from H. Lee Moffitt Cancer Center & Research Institute Blood and Marrow